Frequently Asked Questions (FAQs) Q
Other Pituitary Hormones No clinically significant changes in the levels of other pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH) and prolactin, were observed in subjects receiving tesamorelin in Phase 3 clinical trials
Glutamate, aspartate, and SP released in the SC in response to formalin s.c
It is a risk-stratified framework
Ongoing treatment is an option: Some people use long-term or adjusted dosing to help maintain results, based on their needs
Alcohol should be minimised during retatrutide treatment as it can worsen nausea, impair blood glucose regulation, and increase the risk of hypoglycaemia in people also taking insulin or sulfonylureas